Emerging Role of Bevacizumab in Management of Patients With Symptomatic Hepatic Involvement in Hereditary Hemorrhagic Telangiectasia
American Journal of Hematology - United States
doi 10.1002/ajh.24878
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 24, 2017
Authors
Publisher
Wiley